Red Cat Holdings posted 172% year-over-year revenue growth to $40.7 million, driven by Black Widow drone sales and its BlueOps uncrewed surface vessel program. The stock returned 131% over the past year. It also burned $72.1 million net, trades at a price-to-sales ratio of 34.9x against an industry average of 4.6x, and carries a market cap of roughly $1.3 billion.
That combination — real operational traction, a Japan defense contract, and a valuation that prices in several years of aggressive execution — is what makes RCAT one of the more contested names in the drone stock universe right now.
What the Japan Contract and BlueOps Add to the Story
The contract with Japan’s ATLA for 173 Black Widow units, reported earlier this week, is the most concrete near-term revenue signal. It demonstrates that Red Cat can win allied-nation defense procurement, not just US DoD awards, which expands the addressable market meaningfully.
BlueOps is the longer-duration bet. Red Cat is targeting production capacity of 500 to 1,000 uncrewed surface vessels per year at unit prices between roughly $750,000 and $1.5 million. If that scales, it transforms Red Cat from a small tactical drone manufacturer into a multi-platform defense systems company — a different valuation story entirely. If it doesn’t, the current P/S ratio has no floor.
What the Valuation Requires
The most-followed analyst narrative on RCAT pegs fair value at $17 against a recent close of $11.72, implying roughly 45% upside. That gap only closes if manufacturing spend is absorbed by order volume, margins improve as production scales, and share dilution stays contained.
At 34.9x price-to-sales versus a peer median of 17.6x and an industry average of 4.6x, the market is already pricing in a scenario where Black Widow demand compounds, BlueOps reaches meaningful production, and international contracts continue. Each of those assumptions needs to hold simultaneously.
Red Cat’s 90-day return of 13.2% suggests the market is incrementally gaining conviction. Whether the Japan contract and BlueOps trajectory are enough to sustain that momentum through the next earnings report will be the near-term test.
